DALLAS, June 11 /PRNewswire-USNewswire/ -- Even in an economy that's proved devastating to charitable giving and government
The multiple grants will benefit a diverse array of research programs at BIIR, all of which share a common goal: more effective health care that saves, prolongs and improves lives.
Michael Ramsay, M.D., president of the Baylor Research Institute, sums it up: "These clinical trials are all addressing immediate clinical needs."
"The world-class investigators at BIIR are getting strong peer recognition for their scientific discoveries with this very significant grant support," adds Dr. Ramsay. "The community has also been very generous with philanthropic support which is essential to seed research projects and fill in much needed funds when expenses exceed the grants."
"These awards are due to the extraordinary efforts of our physicians, scientists, researchers and staff," says Jacques Banchereau, PhD, director of BIIR. He says that a history of successful research, along with a consistent ability to translate results into real-world applications, gives BIIR an edge. "These grants are crucial to continuing research, given the expense of studies in human health care. As it is at academic institutions, considerable external funding is required to progress," explains Dr. Banchereau.
Dr. Ramsay adds that critical funding for the institute comes from other sources as well, including support from Baylor Health Care System, from commercial and industry partners and from generous philanthropic giving from the local community. "It's thanks to this additional support that BIIR can bring the latest advances to patients in a timely manner."
Dr. Ramsay is also hopeful that 2010 will continue the critical trend of sufficient funding for BIIR's industry-leading medical research. He notes that BIIR scientists have applied for numerous grants which are still pending.
About Baylor Research Institute
Baylor Research Institute (BRI) is a leading research center focused on bringing clinical research findings from the laboratory and making them accessible to patient populations of all types. This concept of "bench-to-bedside" makes the patient the top priority as BRI works to understand the origin of a disease, identify potential treatments or preventative therapies and enroll patients in research trials. With more than 900 active research projects by 300 investigators in 20 medical specialties, the institute is nationally and internationally recognized for developing therapies that advance the care and well-being of our community through basic science, translational research, continuity across therapeutic areas and clinical trials.
As part of Dallas-based Baylor Health Care System, and supported by leading clinicians and world-class scientists, BRI specializes in several key areas including: immunology and its clinical indications (such as cancer), autoimmune diseases, rheumatology, and dermatology as well as transplantation, metabolic diseases, cardiovascular disease, infectious diseases and oncology. Research in these areas is bringing the latest discoveries from the laboratory to the patient populations across the country and around the world.
For more information on BRI, please visit www.BaylorHealth.edu/Research/.
SOURCE Baylor Research Institute
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All